Cell Culture Market Size, Share, Statistics & Trends Analysis Report by Product, by Application, by End-User, by Region, and Segment Forecasts 2020 to 2027

The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

Major Trends in Cell Culture Market 

Key drivers of the cell culture industry include the growing prevalence of chronic diseases and cancer fueling its rapid research using cell cultures. The rising investments in cell culture-based therapies will bolster the growth of the market in the coming years. The continuous technological advancements in cell culture study will drive the expansion of the cell culture industry.

 

 

Cell culture is a technique, which involves obtaining cells from animals or plants. These obtained cells are then subjected to artificial growth medium. Furthermore, the entire technique involves the use of tools, which are called as instruments. For instance, some of the instruments include bioreactors, cell culture vessels, and others. Moreover, bioreactors are used to carry out biological reaction, which is used to culture aerobic cells.

 

Cell culture techniques in cancer research

The severity of the cancer disease is a huge burden on the healthcare and pharmaceutical industry. As per the estimates of WHO cancer was the leading cause of death in 2020 accounting for approximately 10 million or one in six deaths. Hence government authorities are pumping up resources into biomedical research for understanding cancer cells and producing relevant anti-cancer drugs for efficient treatment. Cell culture methods are widely used by academicians to study tumor-containing cells. This will propel the growth of the cell culture industry in the forthcoming years. High throughput screening using cell-based arrays is usually the starting point for determining compounds in drug discovery programs. The research activities are slowly transitioning towards 3D cell structures using anchorage methodology or a substrate with attached cells. Many anti-cancer therapeutics have been developed based on tumor cells cultured in a 3D environment. The sensitivity to drugs or natural compounds provides a clear picture of the molecular activity inside the intracellular structures.

Cell culture-based therapies

The advent of omics technologies and metagenomics led to the establishment of cell line structures for detecting cellular mutations, alterations, and genetic variations. Particularly the extracellular vesicles hold significant potential for the treatment of a wide range of diseases and for introducing stem cell-based therapies into the market. This will surge the growth of the cell culture industry in the upcoming years. Several biological parameters are being researched such as functionalization, aggregates, organoids, etc. Then there is media composition optimization such as viscosity, osmolarity, and xeno-free compounds. The chemical and physical properties are also checked such as mechanical loading, pre-conditioning of cytokines, oxygen concentration, and feeding strategies.

Cell culture technologies

The advent of metagenomics has led to deep sequencing techniques that allow analyzing the genome of a microorganism without isolating the virus in cell culture. The huge throughput screening and amplified DNA sequencing aid in the final identification of the agent. The assigned primers increase the template for sequencing and the associated electron microscopy recognizes emerging diseases easily through laboratory diagnosis. Moreover, rapid detection of cell cultures is an effective method for readily using cell structures for time-sensitive cases. This will boost the growth of the global cell culture market in the subsequent years. Moreover, transgenic technology is being utilized. Stable genomic materials are mixed with the cells. Whenever any virus enters the cellular structure many virus-specific enzymes are created for quick measurement of the bacterial and viral origin structures. A more rapid version exists that does not require any medical expertise, is specific, and is very simple to use.

Based on product, the consumables segment will grow the highest in the cell culture market share due to repeated usage and rising funding in biomedical research.

Based on end-user, the pharmaceutical and biotechnology companies segment will witness considerable growth in the cell culture market share due to the growing number of pharma companies and quick regulatory approvals for cell culture vaccines.

In 2019, North America accounted for the major share of cell culture market size and is expected to continue this trend owing to surge in prevalence of cancer and rise in cancer related research. Furthermore, easy availability of cell culture instruments and consumables due to presence of majority of key players boost the growth of the market in the region. Moreover, other factors such as surge in health expenditure also boost the growth of the cell culture market in North America.

However, Asia-Pacific is expected to exhibit fastest growth rate owing to surge in awareness related to use of cell culture technique, development of the R&D sector and surge in research funding. Furthermore, focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the cell culture market in the region.  

 

 

Major players operating in the market include, Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.

Key Benefits for Stakeholders

Cell Culture Market Segments

By Product

By Application

 

By End User

By Region

Major Key Players in the Cell Culture Market

These players are not profiled in the report. The same will be included on request.